EXECUTIVE COMMITTEE ON GLOBAL HEALTH AND HUMAN SECURITY

2007–Present

The Executive Committee on Global Health and Human Security is a unique public-private platform that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field. Under the chairmanship of Professor Keizo Takemi, the committee holds quarterly meetings to provide a venue for unofficial exchanges of views and information sharing among government ministries, academia, private companies, and civil society organizations in Japan. Global health experts from Japan and overseas are invited to speak at the meetings to offer their knowledge and advice.

The committee was initially launched in 2007 as the Working Group on Challenges in Global Health and Japan’s Contributions to prepare policy recommendations for the G8 Hokkaido Toyako Summit the following year. The committee is an integral part of the Global Health and Human Security Program of JCIE, which manages all aspects of the committee’s work.

WORKING GROUPS

In addition to its regular meetings, the following is a select list of some of the working groups and task forces established under the Executive Committee’s auspices:

PROGRAM ACTIVITIES


Reformulating Japan's Global Health ODA to Meet Changing Global Needs

January 30, 2020 | Bangkok, Thailand

More than 30 senior government officials, health experts, and leaders from international organizations gathered to discuss the direction Japan should take to improve its developmental assistance for h…


Policy Recommendations for the 2016 G7 Summit in Japan: Toward Resilient and Sustainable Universal Health Coverage (UHC)

January 27, 2016 | Bangkok, Thailand

At this side event to the 2016 Prince Mahidol Award Conference (PMAC), members of JCIE’s Global Health Working Group (GHWG) presented their draft policy recommendations for the G7 Ise-Shima Summit in…


Dissemination Seminar in Africa—Global Action for Health System Strengthening

April 17–18, 2009 | Nairobi, Kenya

A final dissemination seminar for the Global Action for Health System Strengthening report was held in Nairobi, in collaboration with the African Medical and Research Foundation (AMREF), on April 17–1…


Dissemination Seminars in the United States—Global Action for Health System Strengthening

March 17–19, 2009 |

Two dissemination seminars for Global Action for Health System Strengthening were organized in Washington DC, one on March 17, 2009, that was organized in collaboration with the Center for Global Deve…


Dissemination Seminar in Asia—Global Action for Health System Strengthening

January 27, 2009 | Bangkok, Thailand

The primary goal of this seminar was to share with a broad group of global health stakeholders the outcomes of a recent report produced by an international task force of global health experts.


International Conference on Global Action for Health System Strengthening

November 3–4, 2008 | Tokyo, Japan

A high-level international conference was convened in Tokyo on November 3–4, 2008, to explore the creation of a global strategic framework for strengthening health systems in developing countries arou…

REPORTS


A COVID-19 Emergency Response Strategy—Establishing Domestic Vaccine Development Capacity During a Public Health Emergency

Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security

2021

In light of the COVID-19 pandemic, JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia recommends greater efforts to achieve regulatory harmonization in…


Japan’s Global Health Diplomacy in the Post-COVID Era—The Paradigm Shift Needed on ODA and Related Policies

Special Commission on Japan’s Strategy on Development Assistance for Health

2020 & 2021

A report from a high-level commission organized by JCIE calls for the Japanese government to better coordinate and strategize its health ODA by creating a centralized “control tower” and to double fun…


Survey of Japanese Legislators: Attitudes on ODA and Global Health

Japan Center for International Exchange (JCIE)

June 2020

A JCIE survey of Japanese legislators finds that 80 percent of the 92 respondents favor steps to increase Japan’s official development assistance (ODA), with most prioritizing funding for health progr…


A UHC Approach to Harmonizing Asian Pharmaceutical and Medical Device Regulations

Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia, Executive Committee on Global Health and Human Security

2020

The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia examines specific areas Japan should tackle in order to promote regulatory har…


Recommendations on Formulating a Grand Design for Asian Pharmaceutical and Medical Device Regulatory Harmonization

Executive Committee on Global Health and Human Security, JCIE

2019

The recommendations of JCIE’s Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia highlight a need for regulatory harmonization and cross-sectoral cooperation.


Advancing a Global Health Agenda in the SDG Era: Enhancing Japan’s Leadership Role in 2019–2020

International Advisory Group on Global Health (IAG)

November 2018

In 2019 and 2020, Japan hosts a range of critical international meetings, from the G20 Summit to the 7th Tokyo International Conference on African Development (TICAD 7), and the Nutrition for Growth S…


Protecting Human Security: Proposals for the G7 Ise-Shima Summit in Japan

Global Health Working Group for the 2016 G7 Summit

May 21, 2016

In this article in the prestigious Lancet, the Japan Global Working Group offers comprehensive policy recommendations on three areas for global health action by the G7 countries to enhance human secur…


Global Action for Health System Strengthening: Policy Recommendations to the G8

Task Force on Global Action for Health System Strengthening

2009

This report was submitted to the Japanese and Italian governments in January 2009 for consideration for the 2009 G8 Summit agenda.

EXECUTIVE COMMITTEE MEMBERS

CHAIR

Keizo Takemi

Member, House of Councillors; Senior Fellow, Japan Center for International Exchange (JCIE)

DIRECTOR

Akio Okawara

President and CEO, JCIE

SENIOR ADVISORS

Ichiro Aisawa

Member, House of Representatives

Katsunobu Kato

Member, House of Representatives

Yasuhisa Shiozaki

Member, House of Representatives

Norihisa Tamura

Member, House of Representatives

MEMBERS

Yasuhiro Fujiwara

Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Yasumasa Fukushima

Medical Commissioner, Ministry of Health, Labour and Welfare

Motohisa Furukawa

Member, House of Representatives

Noriko Furuya

Member, House of Representatives

Sho Hashimoto

Executive Board Member, Japan Medical Association

Haruhiko Hirate

President, Hirate & Associates

Naoki Ikegami

Professor, Graduate School of Public Health, St. Luke’s International University

Masaki Inaba 

Representative, Japan CSO Network on Global Health; Policy Advisor, Japan Civil Society Network on SDGs (SDGs Japan)

Sumie Ishii 

Chairperson, JOICFP (Japanese Organization for International Cooperation in Family Planning)

Hiroto Izumi

Special Advisor to Prime Minister

Masamine Jimba

Professor, Department of Community and Global Health, Graduate School of Medicine, University of Tokyo

Yasushi Katsuma

Professor, International Studies Program, Graduate School of Asia-Pacific Studies (GSAPS); Head of Global Health Affairs & Governance Group, Institute for Global Health Policy (iGHP), the National Center for Global Health & Medicine (NCGM)

Kiyoshi Kodera

Chair of the Board, Water Aid Japan

Norihiro Kokudo

President, National Center for Global Health and Medicine

Tatsuya Kondo

President, Medical Excellence JAPAN (MEJ); Honorary Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

Kiyoshi Kurokawa

Adjunct Professor, National Graduate Institute for Policy Studies (GRIPS); Chairman, Health and Global Policy Institute

Kenichi Matsumoto

Chairperson, The Japan Federation of Medical Devices Associations

Asahiko Mihara

Member, House of Representatives

Atsushi Mimura

Deputy Director-General, International Bureau, Ministry of Finance

Masanori Miyazaki

President, National Institute of Public Health

Nobuyuki Morishima

Vice President and Representative Director, Otsuka Pharmaceutical Co.

Yoshinori Murata

Director-General, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology (MEXT)

Haruo Naito

President and CEO, Eisai Co., Ltd.; Vice President, Japan Pharmaceutical Manufacturers Association (JPMA)

Yasuhide Nakamura

Professor, School of Nursing, Konan Women’s University; President, WHO Association of Japan

Hiroki Nakatani

Project Professor, Senior Researcher, Keio Global Research Institute (KGRI), Keio University

Catherine Kaseri Ohura

Executive Director and CEO, Global Health Innovative Technology Fund (GHIT)

Takako Ohyabu

Chief Global Corporate Affairs Officer, Takeda Pharmaceutical Company Ltd.

Shigeru Omi

President, Japan Community Healthcare Organization (JCHO); Regional Director Emeritus, World Health Organization for Western Pacific Region

Keiichi Ono

Director-General for Global Issues, Ministry of Foreign Affairs

Yohei Sasakawa

Chairman, Nippon Foundation

Atsushi Seike

President, Promotion and Mutual Aid Corporation for Private Schools of Japan; Executive Advisor for Academic Affairs, Keio University

Johtaro Seki

President, International Total Engineering Corporation (ITEC)

Yukio Takasu

United Nations Under-Secretary-General for Management

Isao Teshirogi

President and CEO, Shionogi & Co., Ltd.

Nobuko Kayashima

Senior Vice President, Japan International Cooperation Agency (JICA)

Akira Yasui

Councillor, Director-General, Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat

Kenji Yasukawa

President and CEO, Astellas Pharma Inc. 

 

as of October 2020

 

The Executive Committee was founded by and is organized by JCIE with the generous support of the Bill & Melinda Gates Foundation.